Another new drug for type 2 diabetes, called Prandin (repaglinide)
You'll soon see another new drug for type 2 diabetes, called Prandin (repaglinide).
It's the first of a new class...the meglitinides.
Prandin is given before meals to reduce postprandial hyperglycemia. It stimulates the pancreas to release more insulin.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote